Some basic chart analysis on Genmab.
This is more to bring your attention to the stocks long term growth prospects.
With a TTM P/E ratio of 29 and a FWD of 3, combined with solid revenue growth TTM and FWD leads me to suggest that Genmab will thrive in the coming months and climb to all time highs.
This is a classic high growth stock. Making huge amounts of cash and growing quickly. Opening new market in New York after already dominating in Australia.
Trend up with a consolidation pattern going on. I would wait till a high move breaking into fresh air before adding to my already large position.
A2 Milk for those unsure is based on some cows...